SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Thursday broker round-up UPDATE

Thu, 09th Oct 2014 09:27
African Barrick Gold: Numis reduces target price from 330p to 270p keeping its hold recommendation.Antofagasta: Numis upgrades to hold with a target price of 700p.Aureus Mining: Numis lowers target price from 45p to 40p staying with its buy recommendation.Boohoo: Barclays initiates with a target price of 65p and an overweight rating.Brown (N) Group: N+1 Singer places both its target price (prev.: 585p) and its buy recommendation under review. Investec places both its target price (prev.: 520p) and its buy recommendation under review.Burberry Group: Deutsche Bank ups target price from 1550p to 1600p keeping its hold recommendation.BTG: N+1 Singer raises target price from 486p to 611p, but still recommends selling.Caledonia Mining: Numis lowers target price from 90p to 85p and stays with its buy recommendation.Centamin: Numis lowers target price from 70p to 60p leaving its hold recommendation unchanged.Chaarat Gold: Numis lowers target price from 30p to 25p and keeps a buy recommendation.Condor Resources: Numis lowers target price from 110p to 100p, while staying with its buy recommendation.Consort Medical: N+1 Singer reduces target price from 1100p to 950p and downgrades from buy to hold. Canaccord Genuity reduces target price from 1182p to 996p and keeps a buy recommendation.Direct Line: JP Morgan cuts target price from 280p to 240p and maintains a neutral rating.Dunelm: JP Morgan upgrades to overweight with a target price of 1000p.Electrocomponents: Canaccord Genuity reduces target price from 313p to 200p downgrading to hold.Euromoney: Westhouse Securities cuts target price from 1090p to 1063p and reiterates a neutral rating.Europa Oil & Gas: Northland Capital shifts target price from 10.3p to 11.1p reiterating its buy recommendation.Ferrexpo: Numis cuts target price from 140p to 100p and stays with its hold recommendation.First Quantum Minerals: Numis upgrades to buy with a target price of 1500p.Fresnillo: Numis reduces target price from 1250p to 1100p keeping its buy recommendation.Green Dragon Gas: Cantor Fitzgerald initiates with a target price of 952p and a buy recommendation.Highland Gold: Numis lowers target price from 100p to 90p and retains a buy recommendation.Hochschild Mining: Numis cuts target price from 160p to 140p and retains a hold recommendation.HSBC Holdings: Investec ups target price from 620p to 650p and upgrades to add.InterContinental Hotels Group: Credit Suisse raises target price from 1980p to 2130p staying with its underperform rating.Investec: Barclays initiates with an overweight rating.Kazakhmys: Numis lowers target price from 290p to 280p and retains a hold recommendation.Man Group: Panmure Gordon ups target price from 125p to 145p upgrading to buy.Minera IRL: Numis lowers target price from 20p to 15p and maintains a buy recommendation.Northbridge: Westhouse Securities raises target price from 571p to 690p maintaining a buy recommendation.Petra Diamonds: Numis moves target price from 240p to 250p upgrading to buy.Petropavlovsk: Numis lowers target price from 30p to 20p, while upgrading to reduce.Polar Capital: Numis cuts target price from 490p to 475p and leaves its add rating unchanged. Canaccord Genuity cuts target price from 667p to 615p reiterating a buy recommendation.Punch Taverns: Numis upgrades from hold to buy with a target price of 10p.Randgold Resources: Numis reduces target price from 5800p to 51000p, while upgrading to buy.Scapa: Numis shifts target price from 145p to 150p and upgrades from hold to add.Spirent: Numis reduces target price from 135p to 80p and downgrades from buy to add. Canaccord Genuity reduces target price from 120p to 80p retaining a hold recommendation. Liberum Capital lowers target price from 100p to 90p retaining a hold recommendation.Supergroup: Berenberg lowers target price from 1490p to 1480p, while retaining its buy recommendation.Vodafone: Nomura lowers target price from 190p to 180p and downgrades to reduce.Wolf Minerals: Numis lowers target price from 23p to 21p and keeps a buy recommendation.

Related News

LONDON MARKET MIDDAY: FTSE pares gains as US-Iran deal lifts sentiment
1 hour ago

LONDON MARKET MIDDAY: FTSE pares gains as US-Iran deal lifts sentiment

(Alliance News) - Stock prices in London surrendered much of their early advance by midday on Monday, although remained in positive territory as inves...

WINNERS & LOSERS: Mining and travel stocks soar as Iran deal hits oil
2 hours ago

WINNERS & LOSERS: Mining and travel stocks soar as Iran deal hits oil

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Monday.

LONDON BROKER RATINGS: Exane BNP raises Halma; Shore says 'buy' boohoo
3 hours ago

LONDON BROKER RATINGS: Exane BNP raises Halma; Shore says 'buy' boohoo

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

CSRT.L News

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition
17 Feb 2020

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition

Monday broker round-up
10 Feb 2020

Monday broker round-up

(Sharecast News) - Consort Medical: RBC Capital Markets upgrades to sector performer with a target price of 1,010p.

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional
4 Feb 2020

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional

Recipharm To Make No Further Changes To Consort Medical Offer
29 Jan 2020

Recipharm To Make No Further Changes To Consort Medical Offer

Recipharm To Make No Further Changes To Consort Medical Offer

Recipharm Extends Consort Medical Offer Deadline To February 4
24 Jan 2020

Recipharm Extends Consort Medical Offer Deadline To February 4

Recipharm Extends Consort Medical Offer Deadline To February 4

Recipharm Buys 10% Of Takeover Target Consort Medical
22 Jan 2020

Recipharm Buys 10% Of Takeover Target Consort Medical

Recipharm Buys 10% Of Takeover Target Consort Medical

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle
14 Jan 2020

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle

Friday broker round-up
10 Jan 2020

Friday broker round-up

(Sharecast News) - Polymetal International: Berenberg upgrades to buy with a target price of 1,480p.